Shielding of hepatitis B virus-like nanoparticle with poly(2-ethyl-2-oxazoline)
Virus-like nanoparticles (VLNPs) have been studied extensively as nanocarriers for targeted drug delivery to cancer cells. However, VLNPs have intrinsic drawbacks, in particular, potential antigenicity and immunogenicity, which hamper their clinical applications. Thus, they can be eliminated easily...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI
2019
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/38249/1/38249.pdf http://psasir.upm.edu.my/id/eprint/38249/ https://www.mdpi.com/1422-0067/20/19/4903 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|